Hexapradol
Hexapradol (INN) is a psychostimulant drug which was never marketed.[1]
Clinical data | |
---|---|
Other names | α-butyl-β-hydroxy-β-phenylamphetamine α-pentyl-β-hydroxy-β-phenyl-2-phenethylamine β-phenyl-2-phenylheptanolamine |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C19H25NO |
Molar mass | 283.415 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Synthesis
Synthesis methods are described.[3]
References
- Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. Vol. 2. CRC Press. p. 1023. ISBN 978-0-412-46630-4. Retrieved 26 April 2012.
- Scuri R, Mondani G, Fantini PL, Dàlla Valle V, Valsecchi B (September 1984). "Hexaprazol: a new antiulcer drug with a cytoprotective action". Bollettino Chimico Farmaceutico. 123 (9): 425–38. PMID 6529496.
- GB 805511, "1,1-diaryl-2-aminoalkanols", published 1958-12-10, assigned to Mead Johnson & Co.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.